France welcomes the partnership agreement signed on September 24 between Unitaid, an organization co-founded and majority-funded by France, and Dr. Reddy’s Laboratories, the Clinton Health Access Initiative (CHAI) and Wits RHI.
This agreement will make it possible to produce and distribute a generic form of lenacapavir in 120 low- and middle-income countries for just $40 per person per year as soon as 2027. This treatment prevents HIV/AIDS infections with unprecedented effectiveness – (…)
Prevention of HIV/AIDS – Historic Unitaid agreement to make lenacapavir accessible to low-income countries (September 25, 2025)
